Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Treasury Shares (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Treasury Shares for 12 consecutive years, with $10.7 million as the latest value for Q1 2021.

  • Quarterly Treasury Shares changed 0.0% to $10.7 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $10.7 million through Mar 2021, changed 0.0% year-over-year, with the annual reading at $10.7 million for FY2020, 0.0% changed from the prior year.
  • Treasury Shares for Q4 2025 was $164080.0 at Harvard Bioscience, down from $1.7 million in the prior quarter.
  • The five-year high for Treasury Shares was $2.1 million in Q1 2023, with the low at $164080.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $1.0 million, with a median of $1.0 million recorded in 2023.
  • Peak annual rise in Treasury Shares hit 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
  • Over 5 years, Treasury Shares stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $10.7 million, $10.7 million, and $10.7 million for Q1 2021, Q4 2020, and Q3 2020 respectively.